Inactive Instrument

Phase Holographic Imaging PHI AB Share Price Swiss Exchange

Equities

SE0005504636

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- SEK - Intraday chart for Phase Holographic Imaging PHI AB

Financials

Sales 2022 8.17M 776K 60.9M Sales 2023 9.9M 941K 73.81M Capitalization 100M 9.52M 747M
Net income 2022 -25M -2.38M -186M Net income 2023 -23M -2.19M -171M EV / Sales 2022 12.8 x
Net Debt 2022 23.8M 2.26M 177M Net Debt 2023 17.12M 1.63M 128M EV / Sales 2023 11.9 x
P/E ratio 2022
-3.18 x
P/E ratio 2023
-4.24 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 54.35%
More Fundamentals * Assessed data
Phase Holographic Imaging Obtains SEK7 Million Loan Agreement MT
Phase Holographic Imaging PHI AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Phase Holographic Imaging PHI AB Appoints Ivan Jurkovic as Ordinary Board Member CI
Phase Holographic Imaging Presents a Comprehensive Opinion Piece Delivering the Versability and Potential the Company sees for Quantitative Phase Imaging Technology in Regenerative Medicine CI
Phase Holographic Imaging Reports Sales Results for the Third Quarter of 2024 CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the First Quarter Ended July 31, 2023 CI
European Patent Office Intends to Grant Phase Holographic Imaging AB Patent on Synthetic Antibodies CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023 CI
Phase Holographic Imaging Phi AB Elects Goran Dubravcic Elected as A New Member of the Board CI
Altium Mitkap AG acquired a 11.8% stake in Phase Holographic Imaging PHI AB from Formue Nord A/S. CI
PHI expands its global network to India CI
Phase Holographic Imaging Announces Management Changes CI
Phase Holographic Imaging PHI AB Announces Management Changes CI
Phase Holographic Imaging PHI AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 60 31/08/18
Founder 61 02/06/97
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 78 31/12/11
Director/Board Member 76 31/12/13
Founder 61 02/06/97
More insiders
Phase Holographic Imaging PHI AB (PHI) is a Sweden-based company active in the field of medical technology. It develops and markets time-lapse cytometers for clinical applications. The products use holographic microscopy technology, with image sensors capturing light information from objects, and computer processing the information to create visual image. It is also engaged in the development of related software. Its method allows to view and measure living cell over time, without disturbing or destroying it. PHI collaborates with cancer- and stem cell researchers, among others. The Company’s product portfolio includes HoloMonitor M3, a bench-top time-lapse cytometer, and HoloMonitor M4, allowing cell analysis in the cultivation incubator.
More about the company